AI Breaks Into Cell Therapy Manufacturing: First Robot to Produce NK Cells at Scale
A machine-vision-guided robot capable of manufacturing natural killer cells at scale was revealed at a biotech summit, while NVIDIA's RNAPro model claims to outperform AlphaFold3 on RNA structure prediction.
Two developments at the intersection of AI and biology landed on the same day. At a biotech summit, as @DrPatrick announced, researchers revealed "the world's first robot to manufacture NK cells at scale" — a system that uses machine vision and AI to automate the production of natural killer cells, a type of immune cell used in cancer therapy. The significance is practical: cell therapies are currently bottlenecked by expensive, labor-intensive manual production. Automating this with AI-guided robotics could dramatically reduce costs and increase availability.
Unlock the full briefing
Get every story in today's briefing, the full archive, and the daily AI intelligence brief.
All stories today
Full archive
Daily brief
Cancel anytime. Payments powered by Stripe.